Expanding cross-presenting dendritic cells enhances oncolytic virotherapy and is critical for long-term anti-tumor immunity
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Expanding cross-presenting dendritic cells enhances oncolytic virotherapy and is critical for long-term anti-tumor immunity
Authors
Keywords
-
Journal
Nature Communications
Volume 13, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2022-11-23
DOI
10.1038/s41467-022-34791-8
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Intratumoral expression of IL-7 and IL-12 using an oncolytic virus increases systemic sensitivity to immune checkpoint blockade
- (2020) Shinsuke Nakao et al. Science Translational Medicine
- BATF3 programs CD8+ T cell memory
- (2020) Marco A. Ataide et al. NATURE IMMUNOLOGY
- The receptor DNGR-1 signals for phagosomal rupture to promote cross-presentation of dead-cell-associated antigens
- (2020) Johnathan Canton et al. NATURE IMMUNOLOGY
- Newcastle Disease Virus at the Forefront of Cancer Immunotherapy
- (2020) Bharat Burman et al. Cancers
- Unleashing Type-2 Dendritic Cells to Drive Protective Antitumor CD4+ T Cell Immunity
- (2019) Mikhail Binnewies et al. CELL
- Pathogen molecular pattern receptor agonists: treating cancer by mimicking infection
- (2019) Mark Aleynick et al. CLINICAL CANCER RESEARCH
- Racial and Socioeconomic Disparities in the Delivery of Immunotherapy for Metastatic Melanoma in the United States
- (2019) Waqar Haque et al. JOURNAL OF IMMUNOTHERAPY
- Systemic clinical tumor regressions and potentiation of PD1 blockade with in situ vaccination
- (2019) Linda Hammerich et al. NATURE MEDICINE
- Cooperation between Constitutive and Inducible Chemokines Enables T Cell Engraftment and Immune Attack in Solid Tumors
- (2019) Denarda Dangaj et al. CANCER CELL
- Antiviral interferons induced by Newcastle disease virus (NDV) drive a tumor-selective apoptosis
- (2019) Teridah Ernala Ginting et al. Scientific Reports
- Neoadjuvant oncolytic virotherapy before surgery sensitizes triple-negative breast cancer to immune checkpoint therapy
- (2018) Marie-Claude Bourgeois-Daigneault et al. Science Translational Medicine
- Lysis-independent potentiation of immune checkpoint blockade by oncolytic virus
- (2018) Anton Oseledchyk et al. Oncotarget
- Bystander CD8+ T cells are abundant and phenotypically distinct in human tumour infiltrates
- (2018) Yannick Simoni et al. NATURE
- CD40L coding oncolytic adenovirus allows long-term survival of humanized mice receiving dendritic cell therapy
- (2018) Sadia Zafar et al. OncoImmunology
- The Immune Epitope Database (IEDB): 2018 update
- (2018) Randi Vita et al. NUCLEIC ACIDS RESEARCH
- WDFY4 is required for cross-presentation in response to viral and tumor antigens
- (2018) Derek J. Theisen et al. SCIENCE
- MEK inhibition enhances oncolytic virus immunotherapy through increased tumor cell killing and T cell activation
- (2018) Praveen K. Bommareddy et al. Science Translational Medicine
- Magnitude of Therapeutic STING Activation Determines CD8+ T Cell-Mediated Anti-tumor Immunity
- (2018) Kelsey E. Sivick et al. Cell Reports
- CD4 + T Cell Help Confers a Cytotoxic T Cell Effector Program Including Coinhibitory Receptor Downregulation and Increased Tissue Invasiveness
- (2017) Tomasz Ahrends et al. IMMUNITY
- IFN-γ–related mRNA profile predicts clinical response to PD-1 blockade
- (2017) Mark Ayers et al. JOURNAL OF CLINICAL INVESTIGATION
- NetMHCpan-4.0: Improved Peptide–MHC Class I Interaction Predictions Integrating Eluted Ligand and Peptide Binding Affinity Data
- (2017) Vanessa Jurtz et al. JOURNAL OF IMMUNOLOGY
- Cancer immunotherapy with recombinant poliovirus induces IFN-dominant activation of dendritic cells and tumor antigen–specific CTLs
- (2017) Michael C. Brown et al. Science Translational Medicine
- Expansion and Activation of CD103 + Dendritic Cell Progenitors at the Tumor Site Enhances Tumor Responses to Therapeutic PD-L1 and BRAF Inhibition
- (2016) Hélène Salmon et al. IMMUNITY
- LRRK1 is critical in the regulation of B-cell responses and CARMA1-dependent NF-κB activation
- (2016) Keiko Morimoto et al. Scientific Reports
- TAM Receptor Signaling in Immune Homeostasis
- (2015) Carla V. Rothlin et al. Annual Review of Immunology
- Late-Stage Cancer Patients Remain Highly Responsive to Immune Activation by the Selective TLR8 Agonist Motolimod (VTX-2337)
- (2015) G. N. Dietsch et al. CLINICAL CANCER RESEARCH
- Talimogene Laherparepvec Improves Durable Response Rate in Patients With Advanced Melanoma
- (2015) Robert H.I. Andtbacka et al. JOURNAL OF CLINICAL ONCOLOGY
- Functional Heterogeneity in the CD4+T Cell Response to Murine γ-Herpesvirus 68
- (2015) Zhuting Hu et al. JOURNAL OF IMMUNOLOGY
- Rat bone marrow-derived dendritic cells generated with GM-CSF/IL-4 or FLT3L exhibit distinct phenotypical and functional characteristics
- (2015) M. Ndiaye et al. JOURNAL OF LEUKOCYTE BIOLOGY
- GFP-specific CD8 T cells enable targeted cell depletion and visualization of T-cell interactions
- (2015) Judith Agudo et al. NATURE BIOTECHNOLOGY
- Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer
- (2015) N. A. Rizvi et al. SCIENCE
- Lymphoma: Immune Evasion Strategies
- (2015) Ranjan Upadhyay et al. Cancers
- Dissecting the Tumor Myeloid Compartment Reveals Rare Activating Antigen-Presenting Cells Critical for T Cell Immunity
- (2014) Miranda L. Broz et al. CANCER CELL
- TLR Signals Induce Phagosomal MHC-I Delivery from the Endosomal Recycling Compartment to Allow Cross-Presentation
- (2014) Priyanka Nair-Gupta et al. CELL
- Newcastle disease virotherapy induces long-term survival and tumor-specific immune memory in orthotopic glioma through the induction of immunogenic cell death
- (2014) Carolien A. Koks et al. INTERNATIONAL JOURNAL OF CANCER
- Predicting immunogenic tumour mutations by combining mass spectrometry and exome sequencing
- (2014) Mahesh Yadav et al. NATURE
- Tumor Exome Analysis Reveals Neoantigen-Specific T-Cell Reactivity in an Ipilimumab-Responsive Melanoma
- (2013) Nienke van Rooij et al. JOURNAL OF CLINICAL ONCOLOGY
- Strelka: accurate somatic small-variant calling from sequenced tumor–normal sample pairs
- (2012) Christopher T. Saunders et al. BIOINFORMATICS
- Disparities in the Early Adoption of Chemoimmunotherapy for Diffuse Large B-cell Lymphoma in the United States
- (2012) C. R. Flowers et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Oncolytic Newcastle disease virus for cancer therapy: old challenges and new directions
- (2012) Dmitriy Zamarin et al. Future Microbiology
- Expression of FMS-like Tyrosine Kinase 3 Ligand by Oncolytic Herpes Simplex Virus Type I Prolongs Survival in Mice Bearing Established Syngeneic Intracranial Malignant Glioma
- (2012) Zachary Barnard et al. NEUROSURGERY
- LoFreq: a sequence-quality aware, ultra-sensitive variant caller for uncovering cell-population heterogeneity from high-throughput sequencing datasets
- (2012) Andreas Wilm et al. NUCLEIC ACIDS RESEARCH
- Differential Expression of Ly6C and T-bet Distinguish Effector and Memory Th1 CD4+ Cell Properties during Viral Infection
- (2011) Heather D. Marshall et al. IMMUNITY
- Host type I IFN signals are required for antitumor CD8+T cell responses through CD8α+dendritic cells
- (2011) Mercedes B. Fuertes et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Type I interferon is selectively required by dendritic cells for immune rejection of tumors
- (2011) Mark S. Diamond et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Vesicular Stomatitis Virus Oncolytic Treatment Interferes with Tumor-Associated Dendritic Cell Functions and Abrogates Tumor Antigen Presentation
- (2011) S. Leveille et al. JOURNAL OF VIROLOGY
- Batf3-Dependent CD11blow/− Peripheral Dendritic Cells Are GM-CSF-Independent and Are Not Required for Th Cell Priming after Subcutaneous Immunization
- (2011) Brian T. Edelson et al. PLoS One
- In Situ Vaccination With a TLR9 Agonist Induces Systemic Lymphoma Regression: A Phase I/II Study
- (2010) Joshua D. Brody et al. JOURNAL OF CLINICAL ONCOLOGY
- Induction of type I interferon by RNA viruses: cellular receptors and their substrates
- (2009) Alina Baum et al. AMINO ACIDS
- Antitumoral Immune Response by Recruitment and Expansion of Dendritic Cells in Tumors Infected with Telomerase-Dependent Oncolytic Viruses
- (2009) Edukulla Ramakrishna et al. CANCER RESEARCH
- Cutting Edge: TLR-Dependent Viral Recognition Along with Type I IFN Positive Feedback Signaling Masks the Requirement of Viral Replication for IFN- Production in Plasmacytoid Dendritic Cells
- (2009) Y. Kumagai et al. JOURNAL OF IMMUNOLOGY
- The receptor tyrosine kinase Flt3 is required for dendritic cell development in peripheral lymphoid tissues
- (2008) Claudia Waskow et al. NATURE IMMUNOLOGY
- Batf3 Deficiency Reveals a Critical Role for CD8 + Dendritic Cells in Cytotoxic T Cell Immunity
- (2008) K. Hildner et al. SCIENCE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started